VBI Vaccines
VBIV
#10656
Rank
NZ$3.18 M
Marketcap
NZ$0.11
Share price
0.00%
Change (1 day)
-89.17%
Change (1 year)

EPS for VBI Vaccines (VBIV)

EPS in 2024 (TTM): NZ-$16.49

According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is NZ-$17.24. In 2022 the company made an earnings per share (EPS) of NZ-$22.45 a decrease over its 2021 EPS that were of NZ-$13.77.

EPS history for VBI Vaccines from 1997 to 2024

Annual EPS

Year EPS Change
2024 (TTM)NZ-$16.49
2022NZ-$22.4562.96%
2021NZ-$13.7728.57%
2020NZ-$10.71-54.35%
2019NZ-$23.47-52.58%
2018NZ-$49.4910.23%
2017NZ-$44.9014.29%
2016NZ-$39.28-62.8%
2015NZ-$105.6190.68%
2014NZ-$55.39-7.95%
2013NZ-$60.17-57.97%
2012NZ-$143.18-78%
2011NZ-$650.913151.47%
2010NZ-$20.0223.87%
2009NZ-$16.16-18.48%
2008NZ-$19.8312.08%
2007NZ-$17.69-49.47%
2006NZ-$35.01
2005N/A-100%
2004NZ-$15.5611.94%
2003NZ-$13.90-81.89%
2002NZ-$76.77196.44%
2001NZ-$25.9084.33%
2000NZ-$14.05-65.37%
1999NZ-$40.57-29.45%
1998NZ-$57.5129.61%
1997NZ-$44.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
NZ-$1.62-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
NZ-$6.24-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
NZ-$7.36-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA